Plasma paraoxonase and arylesterase activities in smokers and smokeless tobacco users as Maraş powder

References

• Aviram M, Rosenblat M. (2004). Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304–16
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M, Bisgaier CL, et al. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–90
   PubMed Web of Science ®Google Scholar
• Bagchi M, Balmoori J, Bagchi D, et al. (1999). Smokeless tobacco, oxidative stress, apoptosis and antioxidants in human oral keratinocytes. Free Radic Bio Med 26:992–1000
   PubMed Web of Science ®Google Scholar
• Barr J, Sharma CS, Sarkar S, et al. (2007). Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol Cell Biochem 297:93–9
   PubMed Web of Science ®Google Scholar
• Bazzano LA, He J, Muntner P, et al. (2003). Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138:891–7
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. (1978). Microsomal lipid peroxidation. Meth Enzymol 52:302–10
   PubMedGoogle Scholar
• Danesh J, Whincup P, Walker M, et al. (2000). Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 321:199–204
   PubMed Web of Science ®Google Scholar
• Durak I, Yalcın S, Cimen MYB, et al. (1999). Effects of smoking on plasma and erythrocyte antioxidant defense systems. J Toxicol Environ Health 56:373–7
   PubMed Web of Science ®Google Scholar
• Durrington PN, Mackness B, Mackness MI. (2001). Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473–80
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Wyte CM, La Du BN. (1983). The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126–38
   PubMed Web of Science ®Google Scholar
• Elkiran ET, Mar N, Aygen B, et al. (2007). Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 15:7–48
   Google Scholar
• Frohlich J, Al-Sarraf A. (2013). Cardiovascular risk and atherosclerosis prevention. Cardiovasc Pathol 22:16–18
   PubMed Web of Science ®Google Scholar
• Furlong CE, Richter RJ, Seidel SL, Motulsky AG. (1988). Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am J Hum Genet 43:230–8
   PubMed Web of Science ®Google Scholar
• Haj Mouhamed D, Ezzaher A, Araoud M, et al. (2010). Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers. Ann Biol Clin (Paris) 68:143–7
   PubMedGoogle Scholar
• Halliwell B. (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–58
   PubMed Web of Science ®Google Scholar
• Huen K, Richter R, Furlong C, et al. (2009). Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta 402:67–74
   PubMed Web of Science ®Google Scholar
• Isik B, Ceylan A, Isik R. (2007). Oxidative stress in smokers and non-smokers. Inhal Toxicol 9:767–9
   Google Scholar
• Katanoda K. (2011). Tobacco or health. In the historical context of epidemiology. Circ J 75:2763–4
   PubMedGoogle Scholar
• Kilinc M, Okur E, Kurutas EB, et al. (2004). The effects of Maras powder (smokeless tobacco) on oxidative stress in users. Cell Biochem Funct 22:233–6
   PubMed Web of Science ®Google Scholar
• Kurtul N, Cil MY, Pacaci SD. (2005). Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maraş powder). J Biomed Sci 12:559–63
   PubMedGoogle Scholar
• Kurtul N, Gökpınar E. (2012). Salivary lipid peroxidation and total sialic acid levels in smokers and smokeless tobacco users as Maraş powder. Mediat Inflamm 2012:619293
   PubMed Web of Science ®Google Scholar
• Latha MS, Vijayammal PL, Kurup PA. (1993). Effect of nicotine administration on lipid metabolism in rats. Indian J Med Res 98:44–9
   PubMed Web of Science ®Google Scholar
• Mackness MI, Abbott C, Arrol S, Durrington PN. (1993). The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 294:829–34
   PubMed Web of Science ®Google Scholar
• Mackness MI, Mackness B, Durrington PN. (2002). Paraoxonase and coronary heart disease. Atheroscler Suppl 3:49–55
   PubMed Web of Science ®Google Scholar
• Nair J, Pakhale SS, Bhide SV. (1989). Carcinogenic tobacco specific nitrosamines in Indian tobacco products. Food Chem Toxicol 27:751–3
   PubMed Web of Science ®Google Scholar
• Nakayama T, Kodama M, Nagata C. (1984). Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 75:95–8
   PubMedGoogle Scholar
• Nielsen F, Mikkelsen BB, Nielsen JB, et al. (1997). Plasma malondialdehyde as a biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43:1209–14
   PubMed Web of Science ®Google Scholar
• Nilsson R. (1998). A qualitative and quantitative risk assessment of snuff dipping. Reg Toxicol Pharmacol 28:1–16
   PubMedGoogle Scholar
• Nishio E, Watanabe Y. (1997). Cigarette smoke extracts inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem Biophys Res Commun 236:289–93
   PubMed Web of Science ®Google Scholar
• Polychronopoulos E, Panagiotakos DB, Polystipioti A. (2005). Diet, lifestyle factors and hypercholesterolemia in elderly men and women from Cyprus. Lipids Health Dis 6:4–17
   Google Scholar
• Saitoh F, Noma M, Kawashima N. (1985). The alkaloid contents of sixty nicotine species. Phytochemistry 24:477–80
   Google Scholar
• Senti M, Tomas M, Anglada R, et al. (2003). Interrelationship of smoking, paraoxonase activity, and leisure time physical activity: a population based study. Eur J Intern Med 14:178–84
   PubMedGoogle Scholar
• Shih DM, Gu L, Xia YR, et al. (1998). Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284–7
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Hall JL. (2012). Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol 60:716–21
   PubMed Web of Science ®Google Scholar
• Virani SS, Brautbar A, Davis BC, et al. (2012). Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 125:241–9
   PubMed Web of Science ®Google Scholar
• Weitberg AB, Corvese D. (1999). The effect of epigallocatechin galleate and sarcophytol A on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. JECCR 18:433–7
   Google Scholar
• Yamaguchi Y, Matsuno S, Kagota S, et al. (2001). Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 156:109–17
   PubMed Web of Science ®Google Scholar
• Yildiz D, Liu YS, Ercal N, Armstrong DW. (1999). Comparison of pure nicotine and smokeless tobacco extract-induced toxicities and oxidative stress. Arch Environ Contam Toxicol 37:434–9
   PubMed Web of Science ®Google Scholar